Programmed Remodeling of the Tumor Milieu to Enhance NK Cell Immunotherapy Combined with Chemotherapy for Pancreatic Cancer

Natural killer (NK) cell-based adoptive immunotherapy has demonstrated encouraging therapeutic effects in clinical trials for hematological cancers. However, the effectiveness of treatment for solid tumors remains a challenge due to insufficient recruitment and infiltration of NK cells into tumor tissues. Herein, a programmed nanoremodeler (DASP/H/pp) is designed to remodel dense physical stromal barriers and for dysregulation of the chemokine of the tumor environment to enhance the recruitment and infiltration of NK cells in tumors. The DAS@P/H/pp is triggered by the acidic tumor environment, resulting in charge reversal and subsequent hyaluronidase (HAase) release. HAase effectively degrades the extracellular matrix, promoting the delivery of immunoregulatory molecules and chemotherapy drugs into deep tumor tissues. In mouse models of pancreatic cancer, this nanomediated strategy for the programmed remodeling of the tumor microenvironment significantly boosts the recruitment of NK92 cells and their tumor cell-killing capabilities under the supervision of multiplexed near-infrared-II fluorescence.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Nano letters - 24(2024), 11 vom: 20. März, Seite 3421-3431

Sprache:

Englisch

Beteiligte Personen:

Yang, Xiaohu [VerfasserIn]
Li, Chunyan [VerfasserIn]
Yang, Hongchao [VerfasserIn]
Li, Tuanwei [VerfasserIn]
Ling, Sisi [VerfasserIn]
Zhang, Yejun [VerfasserIn]
Wu, Feng [VerfasserIn]
Liu, Xiaoguo [VerfasserIn]
Liu, Shaoqin [VerfasserIn]
Fan, Chunhai [VerfasserIn]
Wang, Qiangbin [VerfasserIn]

Links:

Volltext

Themen:

Combined treatment
Journal Article
Multiplexed NIR-II fluorescence imaging
Nanomedicine
Quantum dots
Tumor microenvironment

Anmerkungen:

Date Completed 21.03.2024

Date Revised 21.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.nanolett.4c00002

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368672271